Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2024-04-15 | New | $2,109,876 | $2,109,876 | Debt Only | 06b | SEC link |
Name | Role |
---|---|
Peter H. Barber | Director, Executive |
Daniel Di Pietro | Director |
Matthew Wyckoff | Director |